follitropin + sodium chloride + luteinizing hormone

**Follitropin + sodium chloride + luteinizing hormone** is a gonadotropin combination product corresponding in practice to menotropins for injection, supplied as follicle-stimulating hormone activity plus luteinizing hormone activity and reconstituted with sodium chloride for subcutaneous administration. Clinically, this combination is used in infertility treatment to stimulate ovarian follicular development in women undergoing ovulation induction or assisted reproductive technology. The pharmacologic effect is driven by exogenous FSH activity acting at the follicle-stimulating hormone receptor on ovarian granulosa cells and LH activity acting at the luteinizing hormone receptor on theca and related ovarian cells, thereby promoting follicular growth, steroidogenesis, and maturation of oocytes; sodium chloride functions as the diluent or formulation component rather than as the therapeutic driver. The marketed human pharmaceutical product most specifically matching this ingredient set is Menopur, developed and manufactured by Ferring for female infertility indications.

Brand names

Menopur

Other names

menotropins for injectionhuman menopausal gonadotropinsFSH + LH + sodium chloride